BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35743368)

  • 1. Lower-Neck Sparing Using Proton Therapy in Patients with Uninvolved Neck Nasopharyngeal Carcinoma: Is It Safe?
    De Felice F; Vai A; Camarda AM; Iacovelli NA; Orlandi E
    J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743368
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The feasibility of contralateral lower neck sparing intensity modulation radiated therapy for nasopharyngeal carcinoma patients with unilateral cervical lymph node involvement.
    Tang LL; Tang XR; Li WF; Chen L; Tian L; Lin AH; Sun Y; Ma J
    Oral Oncol; 2017 Jun; 69():68-73. PubMed ID: 28559023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node-negative nasopharyngeal carcinoma.
    Zeng L; Sun XM; Chen CY; Han F; Huang Y; Xiao WW; Liu S; Tian YM; Deng XW; Lu TX
    Head Neck; 2014 May; 36(5):687-93. PubMed ID: 23606573
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and toxicities of elective upper-neck irradiation versus whole-neck irradiation of the uninvolved neck in patients with nasopharyngeal carcinoma: A meta-analysis.
    Ding X; Cui X; Cui X; Wang S
    Radiother Oncol; 2023 Nov; 188():109860. PubMed ID: 37625701
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Toxicity Profiles and Survival Outcomes Among Patients With Nonmetastatic Nasopharyngeal Carcinoma Treated With Intensity-Modulated Proton Therapy vs Intensity-Modulated Radiation Therapy.
    Li X; Kitpanit S; Lee A; Mah D; Sine K; Sherman EJ; Dunn LA; Michel LS; Fetten J; Zakeri K; Yu Y; Chen L; Kang JJ; Gelblum DY; McBride SM; Tsai CJ; Riaz N; Lee NY
    JAMA Netw Open; 2021 Jun; 4(6):e2113205. PubMed ID: 34143193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylactic irradiation of cervical lymph nodes for Stage-N0 nasopharyngeal carcinoma].
    Xie FY; Peng M; Hu WH; Han F; Wang X; Xu HM
    Chin J Cancer; 2010 Jan; 29(1):106-10. PubMed ID: 20038321
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of omitting elective neck irradiation to nodal Level IB in nasopharyngeal carcinoma patients with negative Level IB lymph nodes treated by intensity-modulated radiotherapy: a Phase 2 study.
    Li M; Huang XG; Yang ZN; Lu JY; Zhan YZ; Xie WJ; Zhou DJ; Wang L; Zhu DX; Lin ZX
    Br J Radiol; 2016 Sep; 89(1065):20150621. PubMed ID: 27376590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sparing level Ib lymph nodes by intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma.
    Chen J; Ou D; He X; Hu C
    Int J Clin Oncol; 2014 Dec; 19(6):998-1004. PubMed ID: 24337503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart and Cardiac Substructure Dose Sparing in Synchronous Bilateral Breast Radiotherapy: A Dosimetric Study of Proton and Photon Radiation Therapy.
    Sun T; Lin X; Tong Y; Liu X; Pan L; Tao C; Duan J; Yin Y
    Front Oncol; 2019; 9():1456. PubMed ID: 31998635
    [No Abstract]   [Full Text] [Related]  

  • 10. Intensity-modulated proton therapy (IMPT) versus intensity-modulated radiation therapy (IMRT) for the treatment of head and neck cancer: A dosimetric comparison.
    Nguyen ML; Cantrell JN; Ahmad S; Henson C
    Med Dosim; 2021 Autumn; 46(3):259-263. PubMed ID: 33648823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intensity modulated proton therapy (IMPT) - The future of IMRT for head and neck cancer.
    Moreno AC; Frank SJ; Garden AS; Rosenthal DI; Fuller CD; Gunn GB; Reddy JP; Morrison WH; Williamson TD; Holliday EB; Phan J; Blanchard P
    Oral Oncol; 2019 Jan; 88():66-74. PubMed ID: 30616799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The potential of intensity-modulated proton radiotherapy to reduce swallowing dysfunction in the treatment of head and neck cancer: A planning comparative study.
    van der Laan HP; van de Water TA; van Herpt HE; Christianen ME; Bijl HP; Korevaar EW; Rasch CR; van 't Veld AA; van der Schaaf A; Schilstra C; Langendijk JA;
    Acta Oncol; 2013 Apr; 52(3):561-9. PubMed ID: 22708528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy.
    Tang LL; Guo R; Zhou G; Sun Y; Liu LZ; Lin AH; Mai H; Shao J; Li L; Ma J
    PLoS One; 2014; 9(10):e108375. PubMed ID: 25302611
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation.
    Ou X; Shen C; Kong L; Wang X; Ding J; Gao Y; Xu T; Hu C
    Oral Oncol; 2012 Oct; 48(10):1045-1050. PubMed ID: 22633108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma.
    Lu TX; Mai WY; Teh BS; Zhao C; Han F; Huang Y; Deng XW; Lu LX; Huang SM; Zeng ZF; Lin CG; Lu HH; Chiu JK; Carpenter LS; Grant WH; Woo SY; Cui NJ; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):682-7. PubMed ID: 14967420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dosimetric comparison of intensity modulated radiotherapy and intensity modulated proton therapy in the treatment of recurrent nasopharyngeal carcinoma.
    Hung HM; Chan OCM; Mak CH; Hung WM; Ng WT; Lee MCH
    Med Dosim; 2022 Spring; 47(1):14-19. PubMed ID: 34470708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
    Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
    Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0-1) nasopharyngeal carcinoma.
    Chen JZ; Le QT; Han F; Lu LX; Huang SM; Lin CG; Deng XW; Cui NJ; Zhao C
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):929-34. PubMed ID: 22975606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Promising treatment outcomes of intensity-modulated radiation therapy for nasopharyngeal carcinoma patients with N0 disease according to the seventh edition of the AJCC staging system.
    Sun Y; Tang LL; Chen L; Li WF; Mao YP; Liu LZ; Lin AH; Li L; Ma J
    BMC Cancer; 2012 Feb; 12():68. PubMed ID: 22336097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Regulation for distribution of metastatic cervical lymph nodes of 512 cases of nasopharyngeal carcinoma].
    Sun Y; Ma J; Lu TX; Wang Y; Huang Y; Tang LL
    Ai Zheng; 2004 Nov; 23(11 Suppl):1523-7. PubMed ID: 15566672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.